Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
NextCure Inc
2USCurrent price
1.19 EUR
0 EUR (0.00%)
Last closed
1.29 USD
Company
www.nextcure.com
ISIN
US65343E1082
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
36 088 780 USD
Yield for 12 month
+21.43 %
1Y
3Y
5Y
10Y
15Y
2US
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. It has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland. Address: 9000 Virginia Manor Road, Beltsville, MD, United States, 20705
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.33 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 684 000 USD
Last Year
-4 480 000 USD
Current Quarter
–
Last Quarter
-701 000 USD
Key Figures 2US
1 year
3 years
5 years
10 years
EBITDA
-60 403 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-31.09 %
PEG Ratio
–
Return On Equity TTM
-54.75 %
Wall Street Target Price
3.33 USD
Revenue TTM
–
Book Value
4.1 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-54 199 000 USD
Earnings per share
-2.19 USD
Diluted Eps TTM
-2.19 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2US
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2US
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2US
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.623
Price Sales TTM
9.5227
Enterprise Value EBITDA
0.5081
Price Book MRQ
0.4158
Financials 2US
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2US
For 52 weeks
1.03 USD
2.57 USD
50 Day MA
1.37 USD
Shares Short Prior Month
76 093
200 Day MA
1.54 USD
Short Ratio
1.89
Shares Short
73 774
Short Percent
0.28 %
BeatStart